Found 18 results
Author Title [ Type(Asc)] Year
Filters: Author is Wu, J  [Clear All Filters]
Journal Article
S. Shenoy, Eapen, M., Panepinto, J. A., Logan, B. R., Wu, J., Abraham, A., Brochstein, J., Chaudhury, S., Godder, K., Haight, A. E., Kasow, K. A., Leung, K., Andreansky, M., Bhatia, M., Dalal, J., Haines, H., Jaroscak, J., Lazarus, H. M., Levine, J. E., Krishnamurti, L., Margolis, D., Megason, G. C., Yu, L. C., Pulsipher, M. A., Gersten, I., DiFronzo, N., Horowitz, M. M., Walters, M. C., and Kamani, N., A Trial of Unrelated Donor Marrow Transplantation for Children with Severe Sickle Cell Disease, Blood, vol. 128, no. 21, pp. 2561-2567, 2016.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT, Blood, vol. 124, pp. 1372-1377, 2014.
G. A. Yanik, Horowitz, M. M., Weisdorf, D. J., Logan, B. R., Ho, V. T., Soiffer, R. J., Carter, S. L., Wu, J., ,, Difronzo, N. L., Ferrara, J. L., Giralt, S., Madtes, D. K., Drexler, R., White, E. S., and Cooke, K. R., Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol, Biol Blood Marrow Transplant, vol. 20, no. 6, pp. 858-864, 2014.
A. M Zaid, Wu, J., Wu, C., Logan, B. R., Yu, J., Cutler, C., Antin, J. H., Paczesny, S., and Choi, S. W., Plasma Biomarkers of Risk for Death in a Multicenter Phase 3 trial with Uniform Transplant Characteristics Post-Allogeneic HCT, Blood, vol. 129, no. 12, pp. 162-170, 2017.
P. Jacobson, Huang, J., Wu, J., Kim, M., Logan, B., Alousi, A., Grimley, M., Bolanos-Meade, J., Ho, V., Levine, J., and Weisdorf, D., Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-Versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network, Biol Blood Marrow Transplant, vol. 16, pp. 421-429, 2010.
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies, Biol Blood Marrow Transplant, vol. 20, pp. 1485-1492, 2014.
J. Bolanos-Meade, Wu, J., Logan, B. R., Levine, J. E., Ho, V. T., Alousi, A. M., Weisdorf, D. J., and Luznik, L., Lymphocyte Phenotype During Therapy for Acute Graft Versus Host Disease: A Brief Report from BMT CTN 0302, Biol Blood Marrow Transplant, vol. 19, pp. 481-485, 2013.
M. T. Botello-Harbaum, Demko, C. A., Curro, F. A., Rindal, D. B., Collie, D., Gilbert, G. H., Hilton, T. J., Craig, R. G., Wu, J., Funkhouser, E., Lehman, M., McBride, R., Thompson, V., and Lindblad, A., Information-Seeking Behaviors of Dental Practitioners in Three Practice-Based Research Networks, J Dent Educ, vol. 77, pp. 152-160, 2013.
E. K. Waller, Logan, B. R., Harris, W. A., Devine, S. M., Porter, D. L., Mineishi, S., McCarty, J. M., Gonzalez, C. E., Spitzer, T. R., Krijanovski, O. I., Linenberger, M. L., Woolfrey, A., Howard, A., Wu, J., Confer, D. L., and Anasetti, C., Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naive T Cells from Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201, J Clin Oncol, vol. 32, pp. 2365-2372, 2014.
J. Levine, Logan, B., Wu, J., Alousi, A., Ho, V., Bolanos-Meade, J., and Weisdorf, D., Graft-versus-Host Disease Treatment: Predictors of Survival, Biol Blood Marrow Transplant, vol. 16, pp. 1693-1699, 2010.
A. A. King, McKinstry, R. C., Wu, J., and Eapen, M., Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601., Biol Blood Marrow Transplant, 2019.
P. B. Jacobsen, Le-Rademacher, J., Jim, H., Syrjala, K., ,, Logan, B., Wu, J., Majhail, N. S., Wood, W., Rizzo, J. D., Geller, N. L., Kitko, C., Faber, E., Abidi, M. H., Slater, S., Horowitz, M. M., and Lee, S. J., Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902, Biol Blood Marrow Transplant, vol. 20, pp. 1530-1536, 2014.
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., Donor and Recipient Plasma Follistatin Levels are Associated with Acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
C. G. Brunstein, Fuchs, E. J., Carter, S. L., Karanes, C., Costa, L. J., Wu, J., Devine, S. M., ,, Aljitawi, O. S., Cutler, C. S., Jagasia, M. H., Ballen, K. K., Eapen, M., O’Donnell, P. V., and , Alternative Donor Transplantation: Results of Parallel Phase II Trials Using HLA-Mismatched Related Bone Marrow or Unrelated Umbilical Cord Blood Grafts, Blood, vol. 118, no. 2, pp. 282-288, 2011.
J. Levine, Logan, B., Wu, J., Alousi, A., Bolanos-Meade, J., Ferrara, J., Ho, V., Weisdorf, D. J., and Paczesny, S., Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study, Blood, vol. 119, pp. 3854-3860, 2012.